0 citations
Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease
Nature Medicine2017Vol. 23(6), pp. 788–788
Citations Over TimeTop 10% of 2017 papers
Oxford IBD Cohort Investigators, Nathaniel R. West, Ahmed N. Hegazy, Benjamin M. J. Owens, Samuel J. Bullers, Bryan Linggi, Sofia Buonocore, Margherita Coccia, Dieter Görtz, Sébastien This, Felix Stockenhuber, Johanna Pott, Matthias Friedrich, Grigory Ryzhakov, Frédéric Baribaud, Carrie Brodmerkel, Constanze Cieluch, Nahid Rahman, Gerhard Müller‐Newen, Raymond J. Owens, Anja A. Kühl, Kevin J. Maloy, Scott E. Plevy, Satish Keshav, Simon Travis, Fiona Powrie
Related Papers
- → Special Issue “Dietary Bioactive Components in Inflammatory Bowel Disease”(2024)3 cited
- → Origins and Directions of Inflammatory Bowel Disease, Early Studies of the “Nonspecific” Inflammatory Bowel Diseases(2003)6 cited
- → Inflammatory bowel disease and inflammatory molecules: Chickens, eggs and therapeutic targets(2002)1 cited
- → Mo1835 PREVALENCE OF OCULAR DISEASES IN INFLAMMATORY BOWEL DISEASE (IBD): A NATIONAL, POPULATION-BASED STUDY(2020)
- → 31288 Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases(2022)